ReviewInternational journal of oncology2026

IL‑6: A key player in the EGFR‑TKI‑resistant tumor microenvironment and its therapeutic implications (Review).

Qi Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.